ScienceCloud advances collaborative drug discovery with a new generation of integrated applications built on a scalable, cloud-based scientific platform. With no software to manage and no hardware to maintain, ScienceCloud improves operational excellence in globally networked research, significantly reducing IT cost and effort.
As the next step in Accelrys’ externalized collaboration initiative, ScienceCloud takes secure, real-time transfer of project data within geographically-dispersed life science research networks to a new level. ScienceCloud provides project-centered IP storage in a secure information warehouse and enforces sponsor business rules on results posted by network partners.
ScienceCloud enhances the virtual workspace with new mobile applications and tools, allowing project teams to leverage social communication for building and sharing project information. The result is a more holistic collaboration strategy for partnering pharmaceutical and biotechnology companies, contract research organizations (CROs) and academic research teams.
Accelrys senior vice president and chief technology officer Dr Matt Hahn noted today a significant amount of discovery work is done through partner alliances.
"Because of this new business model, life science partner networks need better ways to connect and collaborate than email, e-rooms and repurposed legacy systems. ScienceCloud is a flexible and robust workspace where virtual project teams can securely share the data and apps they need to drive successful outcomes in a fast-changing global and mobile research landscape," Dr Hahn added.